Current Problems in the Use of the Oncolytic Drugs
- 1 January 1968
- journal article
- research article
- Published by Cambridge University Press (CUP) in Acta geneticae medicae et gemellologiae
- Vol. 17 (1) , 270-278
- https://doi.org/10.1017/s1120962300026512
Abstract
Summary 1. Lists have been made of the more frequently occurring malignant diseases and of those commonly available oncolytic drugs which, in the author's opinion, are most appropriate for their treatment. 2. Those tumors which do not usually respond to oncolytic drugs have also been listed. 3. For several malignant diseases it has been found that small doses of oncolytic drugs have proved just as effective for inducing remission and even more effective in prolonging remission than have larger doses of these drugs. The explanation for this may be that smaller doses do less harm to the body's immune defense mechanism than do larger doses.Keywords
This publication has 1 reference indexed in Scilit:
- The Involuting HemangiomaPublished by American Medical Association (AMA) ,1965